佳礼资讯网

 找回密码
 注册

ADVERTISEMENT

楼主: hqg0288220

【KGROUP 0036 交流专区】(前名 DVM)

  [复制链接]
发表于 30-5-2020 08:37 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
RESELLER AGREEMENT BETWEEN PROGENET INNOVATIONS SDN BHD, A SUBSIDIARY OF KEY ALLIANCE GROUP BERHAD ("KAG" OR "THE COMPANY") AND STORM FRONT PTE LTD ("SF")
With reference to the announcement made on 7 April 2020, the Board of Directors of KAG wishes to announce that its subsidiary, Progenet Innovations Sdn Bhd (“Progenet”), has entered into a Reseller Agreement (“RA”) with Storm Front Pte Ltd (“SF”) on 23 April 2020.

Please refer to the attachment for details of the announcement.

The press release in respect of the above, is also attached herewith for the information of Bursa Malaysia Securities Berhad.

This announcement is dated 23 April 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3045848

回复

使用道具 举报


ADVERTISEMENT

发表于 1-6-2020 07:58 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
COLLABORATION AGREEMENT BETWEEN PROGENET INNOVATIONS SDN BHD, A SUBSIDIARY OF KEY ALLIANCE GROUP BERHAD ("KAG" OR "THE COMPANY") AND BINA PURI HOLDINGS BHD ("BPHB")
The Board of Directors of Key Alliance Group Berhad (“KAG” or “the Company”) wishes to announce that Progenet Innovations Sdn Bhd (“Progenet”), a subsidiary of the Company has on 29 April 2020, entered into a Collaboration Agreement (“CA”) with Bina Puri Holdings Bhd (“BPHB”) to bring the respective expertise together to develop a complete suite of Building Information Systems (“BIS”) products to cater for the construction sector, specifically focusing on the current situation which requires additional monitoring and accountability of workforce/human traffic (“Project”).

Please refer to the attachment for details of the announcement.

The press release in respect of the above, is also attached herewith for the information of Bursa Malaysia Securities Berhad.

This announcement is dated 29 April 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3047177

回复

使用道具 举报

发表于 7-6-2020 07:50 AM | 显示全部楼层
KEY ALLIANCE GROUP BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
ESOS
Details of corporate proposal
SHARE ISSUANCE SCHEME (SIS)
No. of shares issued under this corporate proposal
19,500,000
Issue price per share ($$)
Malaysian Ringgit (MYR)   0.0250
Par Value($$) (if applicable)

Latest issued share capital after the above corporate proposal in the following
Units
655,642,836
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 103,143,790.000
Listing Date
19 May 2020
2. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
ESOS
Details of corporate proposal
SHARE ISSUANCE SCHEME (SIS)
No. of shares issued under this corporate proposal
2,700,000
Issue price per share ($$)
Malaysian Ringgit (MYR)   0.0300
Par Value($$) (if applicable)

Latest issued share capital after the above corporate proposal in the following
Units
658,342,836
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 103,243,690.000
Listing Date
19 May 2020

回复

使用道具 举报

发表于 8-6-2020 07:44 AM | 显示全部楼层
Type
Announcement
Subject
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description
KEY ALLIANCE GROUP BERHAD ("KAG" OR THE "COMPANY")PROPOSED PRIVATE PLACEMENT OF UP TO 30% OF THE TOTAL NUMBER OF ISSUED SHARES OF KAG ("PROPOSED PRIVATE PLACEMENT")
On behalf of the Board of Directors of KAG ("Board"), UOB Kay Hian Securities (M) Sdn Bhd ("UOBKH") wishes to announce that the Company proposes to undertake a private placement of up to 30% of the total number of issued shares of KAG to third party investor(s) to be identified later.

Further details of the Proposed Private Placement are set out in the attachment enclosed.

This announcement is dated 19 May 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3051383

回复

使用道具 举报

发表于 10-6-2020 07:35 AM | 显示全部楼层
KEY ALLIANCE GROUP BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
ESOS
Details of corporate proposal
SHARE ISSUANCE SCHEME ("SIS")
No. of shares issued under this corporate proposal
19,500,000
Issue price per share ($$)
Malaysian Ringgit (MYR)   0.0250
Par Value($$) (if applicable)

Latest issued share capital after the above corporate proposal in the following
Units
677,842,836
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 103,789,690.000
Listing Date
27 May 2020
2. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
ESOS
Details of corporate proposal
SHARE ISSUANCE SCHEME ("SIS")
No. of shares issued under this corporate proposal
2,700,000
Issue price per share ($$)
Malaysian Ringgit (MYR)   0.0300
Par Value($$) (if applicable)

Latest issued share capital after the above corporate proposal in the following
Units
680,542,836
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 103,889,590.000
Listing Date
27 May 2020


回复

使用道具 举报

发表于 10-6-2020 08:45 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
KEY ALLIANCE SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF KEY ALLIANCE GROUP BERHAD ("KAG" OR "THE COMPANY") APPOINTED AS REPRESENTATIVE FOR REGISTRATION, MARKETING AND DISTRIBUTION OF COVID-19 RT PCR TEST KITS
The Board of Directors of Key Alliance Group Berhad (“KAG” or “the Company”) wishes to announce that Key Alliance Sdn Bhd (“KASB”), a wholly-owned subsidiary of the Company has on 19th of May 2020, been appointed as representative of ITDF Co Ltd (“ITDF”), as a local partner to effect the registration, and carry out marketing and distribution of the Care Gene Covid-19 RT PCR Kit, produced by Wells Bio Inc (“Appointment”).

Please refer to the attachment for the details of announcement.

The press release in respect of the above, is also attached herewith for the information of Bursa Malaysia Securities Berhad.

This announcement is dated 22 May 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3052511

回复

使用道具 举报

Follow Us
发表于 11-6-2020 06:37 PM 来自手机 | 显示全部楼层
受委韓國IT公司大馬代表·K集團代理冠病試劑盒
(23.05.2020):

(吉隆坡23日訊)K集團(KGROUP,0036,創業板科技組)獨資子公司K集團私人有限公司獲得授權書,以及受委為韓國ITDF公司本地代表,以負責註冊、推銷、行銷和銷售Wells Bio公司的CareGene Covid-19RT PCR試劑盒。

有關授權書讓K集團全權負責與馬來西亞有關當局和政府接洽以註冊PCR試劑盒,以進口、行銷及在本地銷售和分銷。

K集團董事經理何耀基說,“根據當前冠病情況,國際上可能出現第二波的疫情,因此,接下來的幾個月,試劑盒的需求將大幅增加。目前馬來西亞政府正積極為公眾尋找足夠的測試設備以及資源,而一旦經濟恢復正常運作之後,私人界也會開始對此做出貢獻。”

K集團在過去幾個月已經動用現有物聯網(IoT)和軟件夥伴,以落實行動管制令的商業重啟策略,再加上以現有的科技以融入雲端平台,以更自動化、數碼化和整合數據庫協助企業在這個新常態中重新營業。

新聞來源"星州日報":
https://www.klsescreener.com/v2/news/view/680963/%E5%8F%97%E5%A7%94%E9%9F%A9%E5%9B%BDitdf%E5%85%AC%E5%8F%B8%E5%A4%A7%E9%A9%AC%E4%BB%A3%E8%A1%A8-k%E9%9B%86%E5%9B%A2%E4%BB%A3%E7%90%86%E5%86%A0%E7%97%85%E8%AF%95%E5%89%82%E7%9B%92
回复

使用道具 举报

发表于 4-7-2020 08:26 AM | 显示全部楼层
Type
Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID
IQL-28052020-00001
Subject
Key Alliance Sdn Bhd, a wholly-owned subsidiary of Key Alliance Group Berhad, appointed as representative for registration, marketing and distribution of COVID-19 RT PCR Kits, produced by Wells Bio Inc (Appointment)
Description
KEY ALLIANCE SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF KEY ALLIANCE GROUP BERHAD ("KAG" OR "THE COMPANY") APPOINTED AS REPRESENTATIVE FOR REGISTRATION, MARKETING AND DISTRIBUTION OF COVID-19 RT PCR TEST KITS
Query Letter Contents
We refer to your Company’s announcement dated 22 May 2020, in respect of the aforesaid matter.

In this connection, kindly furnish Bursa Securities with the following additional information for public release:-
  • Duration of Appointment and whether renewable. If so, for how long.
  • Authorities with which the test kits will have to be registered, expected date(s) of submission to these authorities, and expected timeframe within which the decision of these authorities will be received.
  • The type of customers to whom the test kits will be marketed/sold.
Further to the announcement on 22 May 2020 and Bursa Malaysia Berhad’s query letter dated 28 May 2020, the Company wishes to furnish additional information in respect of the aforesaid matter as set out below for public release:

  • Duration of the Appointment is effective immediately up till 15th August 2020 and shall be extended automatically with a firm purchase order, or by receipt of a corresponding extension from the principles in the event the registration process extends past the validity date.
  • The Care Gene Covid-19 RT - PCR test kit requires registration and approvals from the Medical Device Authority (MDA). The expected date of submission for the registration and licenses are the 1st week of June. Preliminary groundwork in team building and document preparation has already begun on the 27th of May 2020. The registration is expected to take between 1 to 2 months.
  • The kits will be marketed/sold to private sector corporations/businesses with large workforces, private clinics and private hospitals. A team is currently being established to spearhead this venture.

This announcement is dated 28 May 2020.



回复

使用道具 举报


ADVERTISEMENT

发表于 27-8-2020 07:36 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
KEY ALLIANCE SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF KEY ALLIANCE GROUP BERHAD ("KAG" OR "THE COMPANY") APPOINTED AS REPRESENTATIVE FOR REGISTRATION, MARKETING AND DISTRIBUTION OF COVID-19 RT PCR TEST KITS
Reference is made to the Company’s announcement dated 22 May 2020 and 28 May 2020 whereat Key Alliance Sdn Bhd (“KASB”), a wholly-owned subsidiary of the Company has been appointed as representative of ITDF Co Ltd (“ITDF”), as a local partner to effect the registration, and carry out marketing and distribution of the Care Gene Covid-19 RT PCR Kit, produced by Wells Bio Inc (“Appointment”).

The Board of Directors of Key Alliance Group Berhad (“KAG” or “the Company”) wishes to announce that KASB has, on 19 June 2020, received official notification from Comformity Assessment Bodies (“CAB”) Malaysia, an approved certification body by Medical Device Authority (“MDA”) which is part of Malaysia Ministry of Health body that KASB has passed the initial audit and issued the Good Distribution Practice for Medical Devices (“GDPMD”) Certificate of Conformity, which allows  KASB to act as a local authorised representative, import, storage and handling, warehousing and documentation of medical devices, specifically in vitro diagnostic devices.

This is the first step in order for KASB to be able to be legally allowed to market, distribute and sell the Care Gene Covid-19 RT PCR Test Kits produced by Wells Bio Inc, Korea.

The next immediate step is for KASB to submit for the MDA establishment license which will ensure that KASB is in full compliance with the Ministry of Health and the MDA's requirements for a company to be a licensed distributor of medical supplies.

Consecutively and immediately after, KASB will also submit its product of the Care Gene Covid-19 RT PCR Test Kit to the MDA for special access approval, which will then allow this test kit to be legally marketed and sold in Malaysia.

KAG will keep the market informed on the on-going progress of the application process as it materialises.

This announcement is dated 19 June 2020.



回复

使用道具 举报

发表于 10-10-2020 08:35 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2020
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Mar 2020
31 Mar 2019
31 Mar 2020
31 Mar 2019
$$'000
$$'000
$$'000
$$'000
1Revenue
14,279
14,179
40,091
44,301
2Profit/(loss) before tax
-8,447
-2,611
-18,653
-8,102
3Profit/(loss) for the period
-6,712
-2,171
-16,918
-7,662
4Profit/(loss) attributable to ordinary equity holders of the parent
-6,713
-1,661
-15,779
-6,999
5Basic earnings/(loss) per share (Subunit)
-1.28
-0.34
-3.00
-1.42
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.1147
0.1511

回复

使用道具 举报

发表于 26-10-2020 06:14 AM | 显示全部楼层
本帖最后由 icy97 于 5-3-2021 07:53 AM 编辑

Type
Announcement
Subject
OTHERS
Description
KEY ALLIANCE SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF KEY ALLIANCE GROUP BERHAD ("KAG" OR "THE COMPANY") AWARDED MDA LICENSE
Reference is made to the Company’s announcement dated 22 May 2020, 28 May 2020 and 19 June 2020 whereas Key Alliance Sdn Bhd (“KASB”), a wholly-owned subsidiary of the Company has been appointed as representative of ITDF Co Ltd (“ITDF”), as a local partner to effect the registration, and carry out marketing and distribution of the Care Gene Covid-19 RT PCR Kit, produced by Wells Bio Inc (“Appointment”).

The Board of Directors of Key Alliance Group Berhad (“KAG” or “the Company”) are delighted to announce that KASB has, on 10th of July, received its Establishment License from the Medical Device Authority of Malaysia (MDA), under Section 15 (1) of Act 737 to act as an Authorised Representative, Distributor & Importer of the Wells Bio Care Gene Covid-19 RT PCR Test Kit.

The process for the Wells Bio Care Gene Covid-19 RT PCR to be granted special access is already underway and the Company will keep the market informed on the developments as it arises.

The Board of Directors also are pleased to announce it has appointed Seremban Premier Pharmacy Sdn Bhd (“SPP”) and Custom Medz Sdn Bhd (“CMSB”) as its distributors for the Wells Bio Care Gene Covid-19 RT PCR Test Kit (“Appointment of Distributors”).

SPP has been in operation in the pharmaceutical and medical devices industry for 23 years, with active involvement in government tenders related to RTK and PCR Kits. Its notable procurements are Hospital Kuala Lumpur, Hospital Selayang, Hospital Sultan Aminah, Hospital Sugai Buloh and Hospital Sultan Ismail.

CMSB is Malaysia's First Compounding Pharmacy. Since 2009, CMSB has specialised in compounding of Nutraceuticals, Amino Acids and many more. With laboratory partnerships in Penang, Kuala Lumpur and Jakarta, CMSB are currently involved in the distribution of Covid-19 Antibody Rapid Test Kits to private clinics, hospitals and laboratories.

This announcement is dated 10 July 2020.





Type
Announcement
Subject
OTHERS
Description
SUPPLY AND PURCHASE CONTRACT BETWEEN KEY ALLIANCE SDN BHD, A SUBSIDIARY OF KEY ALLIANCE GROUP BERHAD ("KAG" OR "THE COMPANY") AND ITDF CO. LTD ("ITDF")
Reference is made to the announcements dated 22 May 2020, 28 May 2020, 19 June 2020 and 10 July 2020, the Board of Directors of Key Alliance Group Berhad (“KAG” or “the Company”) wishes to announce that its wholly-owned subsidiary Key Alliance Sdn Bhd (“KASB”) has on 14 October 2020, entered into a Supply and Purchase Contract (“Contract”) with ITDF Co. Ltd. (“ITDF”) to set forth the general binding terms regarding the supply and purchase of the Care Gene COVID-19 RT-PCR Kit (“Product”) between KASB and ITDF, for which transaction shall be fully consummated by means of a purchase order.

Please refer to the attachment for details of the announcement.

The press release in respect of the above, is also attached herewith for the information of Bursa Malaysia Securities Berhad.

This announcement is dated 14 October 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3096108

回复

使用道具 举报

发表于 5-11-2020 09:33 AM | 显示全部楼层
KEY ALLIANCE GROUP BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
Private Placement
Details of corporate proposal
Private placement of up to 30% of the total number of issued shares of Key Alliance Group Berhad
No. of shares issued under this corporate proposal
204,162,850
Issue price per share ($$)
Malaysian Ringgit (MYR)   0.0600
Par Value($$) (if applicable)

Latest issued share capital after the above corporate proposal in the following
Units
884,705,686
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 116,139,361.000
Listing Date
21 Jul 2020

回复

使用道具 举报

发表于 20-11-2020 05:21 AM | 显示全部楼层
Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
KEY ALLIANCE GROUP BERHAD ("KAG" or "the Company")CONVERSION OF IRREDEEMABLE CONVERTIBLE PREFERENCE SHARES IN XOX BERHAD ("XOX")("CONVERSION")
The Board of Directors of KAG wishes to announce that the Company is converting 248,600,000 Irredeemable Convertible Preference Shares (“ICPS”) in XOX to 248,600,000 new ordinary shares at the conversion price of RM0.05 (“Conversion Price”) per share by paying the difference of the aggregate issue price of ICPS surrendered and the Conversion Price.

Please refer the attachment for further details.  

The press release in respect of the above, is also attached herewith for the information of Bursa Malaysia Securities Berhad.

This announcement is dated 28 July 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3072314

回复

使用道具 举报

发表于 23-11-2020 08:37 AM | 显示全部楼层
KEY ALLIANCE GROUP BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
ESOS
Details of corporate proposal
Share Issuance Scheme ("SIS")
No. of shares issued under this corporate proposal
75,000,000
Issue price per share ($$)
Malaysian Ringgit (MYR)   0.0800
Par Value($$) (if applicable)

Latest issued share capital after the above corporate proposal in the following
Units
959,705,686
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 124,636,860.740
Listing Date
04 Aug 2020

回复

使用道具 举报

发表于 1-12-2020 09:29 AM | 显示全部楼层
Type
Announcement
Subject
MULTIPLE PROPOSALS
Description
KEY ALLIANCE GROUP BERHAD ("KAG" OR THE "COMPANY")I.        PROPOSED RIGHTS ISSUE WITH WARRANTS; ANDII.        PROPOSED DIVERSIFICATION(COLLECTIVELY REFERRED TO AS THE "PROPOSALS")
On behalf of the Board of Directors of KAG ("Board"), UOB Kay Hian Securities (M) Sdn Bhd ("UOBKH") wishes to announce that the Company proposes to undertake the following:-

i. a proposed renounceable rights issue of up to 982,205,686 new ordinary shares in KAG ("KAG Share(s)" or "Share(s)") ("Rights Shares") on the basis of 1 Rights Share for every 1 existing KAG Share held, together with up to 982,205,686 free detachable warrants in KAG ("Warrant(s)") on the basis of 1 Warrant for every 1 Rights Share subscribed for on an entitlement date to be determined and announced later ("Proposed Rights Issue with Warrants"); and

ii. a proposed diversification of the Company's existing principal activities to include the marketing, distribution and trading of medical equipment, devices, and related products and accessories ("Proposed Diversification").

Further details of the Proposals are set out in the attachment enclosed.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3075185

回复

使用道具 举报

发表于 11-12-2020 05:45 AM | 显示全部楼层
KEY ALLIANCE GROUP BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
ESOS
Details of corporate proposal
SHARE ISSUANCE SCHEME ("SIS")
No. of shares issued under this corporate proposal
22,500,000
Issue price per share ($$)
Malaysian Ringgit (MYR)   0.1200
Par Value($$) (if applicable)

Latest issued share capital after the above corporate proposal in the following
Units
982,205,686
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 128,092,860.740
Listing Date
14 Aug 2020

回复

使用道具 举报


ADVERTISEMENT

发表于 4-1-2021 08:46 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2020
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Jun 2020
30 Jun 2019
30 Jun 2020
30 Jun 2019
$$'000
$$'000
$$'000
$$'000
1Revenue
7,509
6,598
7,509
6,598
2Profit/(loss) before tax
9,789
-3,858
9,789
-3,858
3Profit/(loss) for the period
9,789
-3,858
9,789
-3,858
4Profit/(loss) attributable to ordinary equity holders of the parent
10,282
-3,498
10,282
-3,498
5Basic earnings/(loss) per share (Subunit)
1.60
-0.67
1.60
-0.67
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.1118
0.1140

回复

使用道具 举报

发表于 27-1-2021 08:52 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
SHAREHOLDER AGREEMENT BETWEEN KEY ALLIANCE GROUP BERHAD (KAG OR THE COMPANY) AND RIMBUNAN DAUN VENTURES SDN BHD (RDV) AND FORTIFOODS SDN BHD (FORTI)
The Board of Directors of Key Alliance Group Berhad (“KAG” or “the Company”) wishes to announce that the Company has on 28 September 2020, entered into a Shareholder Agreement (“SA”) with Rimbunan Daun Ventures Sdn Bhd (“RDV”) and Fortifoods Sdn Bhd (“Forti”) to pariticipate in a joint venture for the purpose of working together to develop and promote an intelligent and integrated in-field rice production management solution also known as the Rice Information Management System (“RIM System”) via joint venture vehicle, Agrocloud Sdn Bhd (Formerly known as Stratus System Sdn Bhd) (“Agrocloud”).

Please refer to the attachment for details of the announcement.

The press release in respect of the above, is also attached herewith for the information of Bursa Malaysia Securities Berhad.

This announcement is dated 28 September 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3091565

回复

使用道具 举报

发表于 15-2-2021 05:58 AM | 显示全部楼层
KEY ALLIANCE GROUP BERHAD

Type
Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID
IQL-30092020-00002
Subject
Shareholder agreement between Key Alliance Group Berhad (KAG) and Rimbunan Daun Ventures Sdn Bhd (RDV) and Fortifoods Sdn Bhd (Forti)
Description
SHAREHOLDER AGREEMENT BETWEEN KEY ALLIANCE GROUP BERHAD (KAG OR THE COMPANY) AND RIMBUNAN DAUN VENTURES SDN BHD (RDV) AND FORTIFOODS SDN BHD (FORTI)
Query Letter Contents
We refer to your Company’s announcement dated 28 September 2020 in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:-
  • The eventual issued share capital of Agrocloud Sdn Bhd (“Agrocloud”).
  • Total capital and investment outlay by KAG in Agrocloud, its sources of funding and breakdown.
  • Expected commencement and completion dates of the Pilot Project.
  • The directors of Agrocloud.
We refer to our announcement dated 28 September 2020 (“Announcement”) and the query from Bursa Securities dated 30 September 2020 (“Bursa Query”). Unless otherwise stated, the terms used throughout this announcement shall have the same meanings as defined in the Announcement.

We wish to announce the following additional information as required by Bursa Securities pursuant to the Bursa Query:

Q1              The eventual issued share capital of Agrocloud Sdn Bhd (“Agrocloud”)
                    Upon completion of the share transfer, the issued share capital of Agrocloud will be RM1,051,000.

Q 2             Total capital and investment outlay by KAG in Agrocloud, its sources of funding and breakdown.
                    KAG is investing RM1,000,000 (Ringgit Malaysia One Million Only) in Agrocloud from internally generated funds.

                    The estimated development cost for the Pilot Project are as below:

Items
RM’000
Hardware, installation and commissioning
200
Platform development
600
Project Management
200

Q3              Expected commencement and completion dates of the Pilot Project.
                    It is expected to commence by October 2020 and it is estimated to be completed by September 2021.

Q4              The directors of Agrocloud
                   The directors nominated by the shareholders of Agrocloud are as below:
                   (a) Mr Roy Ho Yew Kee
                   (b) Y.M. Tengku Ezuan Ismara Bin Tengku Nun Ahmad
                   (c) Mr Nik Amirul Bin Nik Othman
                   (d) Mr Mohd Akmal Bin Abu Hassan
                   (e) Mr Hon Chao Sheung

This announcement is dated 1 October 2020.



回复

使用道具 举报

发表于 25-2-2021 08:34 AM | 显示全部楼层
KEY ALLIANCE GROUP BERHAD

Entitlement subject
Rights Issue
Type
Renounceable
Entitlement description
RENOUNCEABLE RIGHTS ISSUE OF UP TO 982,205,686 NEW ORDINARY SHARES IN KEY ALLIANCE GROUP BERHAD ("KAG" OR THE "COMPANY") ("KAG SHARE(S)") ("RIGHTS SHARE(S)") ON THE BASIS OF 1 RIGHTS SHARE FOR EVERY 1 EXISTING KAG SHARE HELD, TOGETHER WITH UP TO 982,205,686 FREE DETACHABLE WARRANTS IN KAG ("WARRANT(S)") ON THE BASIS OF 1 WARRANT FOR EVERY 1 RIGHTS SHARE SUBSCRIBED FOR, AS AT 5.00 P.M. ON WEDNESDAY, 21 OCTOBER 2020 AT AN ISSUE PRICE OF RM0.05 PER RIGHTS SHARE ("RIGHTS ISSUE WITH WARRANTS")
Ex-Date
20 Oct 2020
Entitlement date
21 Oct 2020
Entitlement time
5:00 PM
Share transfer book & register of members will be
to  closed from (both dates inclusive) for the purpose of determining the entitlement
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers
21 Oct 2020
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit

c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units)
(If applicable)

Rights Issue/Offer Price
Malaysian Ringgit (MYR) 0.0500
Par Value (if applicable)

Entitlement indicator
Ratio
Entitlement Details
Company Name
KEY ALLIANCE GROUP BERHAD
Entitlement
Ordinary Rights
Ratio (New:Existing)
1.0000  : 1.0000
Rights Crediting Date
21 Oct 2020




Despatch Date
23 Oct 2020
Date for commencement of trading of rights
22 Oct 2020
Date for cessation of trading of rights
30 Oct 2020
Date for announcement of final subscription result and basis of allotment of excess Rights Securities
13 Nov 2020
Last date and time for :
Sale of provisional allotment of rights
28 Oct 2020 05:00 PM
Transfer of provisional allotment of rights
02 Nov 2020 04:30 PM
Acceptance and Payment
06 Nov 2020 05:00 PM
Excess share application and payment
06 Nov 2020 05:00 PM
Available/Listing Date
20 Nov 2020

回复

使用道具 举报

您需要登录后才可以回帖 登录 | 注册

本版积分规则

 

ADVERTISEMENT



ADVERTISEMENT



ADVERTISEMENT

ADVERTISEMENT


版权所有 © 1996-2023 Cari Internet Sdn Bhd (483575-W)|IPSERVERONE 提供云主机|广告刊登|关于我们|私隐权|免控|投诉|联络|脸书|佳礼资讯网

GMT+8, 29-3-2024 06:22 PM , Processed in 0.077247 second(s), 21 queries , Gzip On.

Powered by Discuz! X3.4

Copyright © 2001-2021, Tencent Cloud.

快速回复 返回顶部 返回列表